{"id":"W4307723138","doi":"10.1016/j.jaad.2022.10.041","title":"Efficacy and safety of apremilast in patients with mild-to-moderate psoriasis up to 32 weeks: Results from the extension phase of the randomized, phase 3 ADVANCE trial","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"SKiN Health; Bellus Health (Canada); Queen's University; University of British Columbia; Probity Medical Research","funders":"Manitoba Beekeepers' Association; Amgen","keywords":"Apremilast; Medicine; Psoriasis; Randomized controlled trial; Phase (matter); Extension (predicate logic); Internal medicine; Dermatology; Psoriatic arthritis","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01012147,0.0007657989,0.002946462,0.000293728,0.0003942339,0.001500851,0.001148766,0.003251042,0.004633187],"category_scores_gemma":[0.01730175,0.0003829519,0.002351192,0.000442812,0.0006348541,0.001374189,0.0002935474,0.005030926,0.0007949357],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006746729,"about_ca_system_score_gemma":0.001268772,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004140619,"about_ca_topic_score_gemma":0.00115512,"domain_scores_codex":[0.9972937,0.001597702,0.0003602705,0.0002140975,0.0003697283,0.0001645186],"domain_scores_gemma":[0.984097,0.0107317,0.002385046,0.0002737189,0.001796296,0.0007162014],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.327282,0.001550691,0.004328072,0.04271147,0.009845192,0.0009090414,0.0003861065,0.000639837,0.002550176,0.001098599,0.3963063,0.2123925],"study_design_scores_gemma":[0.6227806,0.05217125,0.02865548,0.01600322,0.03043692,0.001527834,0.0003789946,0.003318535,0.004367706,0.004144706,0.2358821,0.0003326937],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.1423642,0.4638693,0.001622947,0.2827623,0.08926404,0.002673998,0.006379972,0.0004450004,0.01061815],"genre_scores_gemma":[0.5015473,0.1239175,0.00423418,0.2234879,0.1239326,0.00318759,0.002967852,0.0002500623,0.01647503],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.01012147,"threshold_uncertainty_score":0.05352807,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01600549215371726,"score_gpt":0.2848892945368695,"score_spread":0.2688838023831522,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}